Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families

Clinical Genetics

Volumn 83, Issue 3, 2013, Pages 215-220

  Burton Chase, A M ^a   Hovick, S R ^a   Peterson, S K ^a   Marani, S K ^a   Vernon, S W ^a   Amos, C I ^b   Frazier, M L ^a   Lynch, P M ^a   Gritz, E R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

Author keywords

Benefits of and barriers to screening; Colonoscopy commitment; Colorectal cancer screening; Genetic counseling and testing; Lynch syndrome

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR; CANCER SCREENING; CLINICAL GENETICS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF CONCEPT;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TIME FACTORS; TRUTH DISCLOSURE;

EID: 84874004402     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12091     Document Type: Article

References (39)

1. Nicolaides NC, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994: 371: 75-80.
2. Papadopoulos N, Nicolaides NC, Liu B et al. Mutations of GTBP in genetically unstable cells. Science 1995: 268: 1915-1917.
3. Fishel R, Lescoe MK, Copeland NG et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993: 75: 1027-1038.
4. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994: 368: 258-261.
5. Palombo F, Gallinari P, Iaccarino I et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995: 268: 1912-1914.
6. Lindor NM, Peterson GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch Syndrome: a systematic review. JAMA 2006: 296: 1507-1517.
7. Lynch H, Lynch JF, Lynch PM, Attard T. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis, and management. Fam Cancer 2008: 7: 27-39.
8. Lynch HT, Lynch JF, Attard TA. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ 2009: 181 (5): 273-280.
9. National Comprehensive Cancer Network (NCCN). Colorectal Cancer Screening Version 2 2011, 2012, from http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed on May 17, 2012.
10. Church J, Simmang C. Standards Task Force; American Society of Colon and Rectal Surgeons; Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of The American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003: 46 (8): 1001-1012.
11. Winawer S, Fletcher R, Rex D, for the multisociety task force on colorectal cancer. Colorectal cancer screening and surveillance. Clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003: 124: 544-560.
12. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007: 44: 353-362.
13. Jarvinen H, Aarnio M, Mustonen H, Aktan-Collan K. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000: 118 (5): 829-834.
14. Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin JP. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009: 27 (28): 4793-4797.
15. Engel C, Rahner N, Schulmann K et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2010: 8 (2): 174-182.
16. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 2005: 14: 1060-1074.
17. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004: 22 (1): 39-44.
18. Hughes Halbert C, Lynch H, Lynch J et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004: 164 (17): 1881-1887.
19. Collins V, Meiser B, Gaff C, St John DJ, Halliday J. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 2005: 104 (2): 273-281.
20. Claes E, Denayer L, Evers-Kiebooms G et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test 2005: 9 (1): 54-65.
21. Ersig AL, Williams JK, Hadley DW, Koehly LM. Communication, encouragement, and cancer screening in families with and without mutations for hereditary non-polyposis colorectal cancer: a pilot study. Genet Med 2009: 11 (10): 728-734.
22. Collins VR, Meiser B, Ukoumunne OC, Gaff C, St John DJ, Halliday JL. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 2007: 9 (5): 290-297.
23. Hadley DW, Jenkins JF, Steinberg SM et al. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol 2008: 26 (6): 948-954.
24. Pylvanainen K, Kairaluoma M, Mecklin JP. Compliance and satisfaction with long-term surveillance in Finnish HNPCC families. Fam Cancer 2006: 5 (2): 175-178.
25. Wagner A, van Kessel I, Kriege MG et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005: 4 (4): 295-300.
26. Stoffel EM, Mercado RC, Kohlmann W et al. Prevalence and predictors of appropriate colorectal cancer screening in Lynch syndrome. Am J Gastroenterol 2010: 105: 1851-1860.
27. Biesecker BB, Marteau TM. The future of genetic counselling: an international perspective. Nat Genet 1999: 22: 133-137.
28. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice Hall, 1986.
29. Rosenstock IM. Historical origins of the Health Belief Model. Heal Educ Monogr 1974: 2 (4): 328-335.
30. Kiviniemi MT, Bennett A, Zaiter M, Marshall JR. Individual-level factors in colorectal cancer screening: a review of the literature on the relation of indivdiual-level health behavior contructs and screening behavior. Psycho-Oncology 2011: 20: 1023-1033.
31. Manne S, Markowitz A, Winawer S et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 2002: 21 (1): 3-15.
32. Vernon SW, Gritz ER, Peterson SK et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 1997: 16 (1): 73-86.
33. Vernon SW, Gritz ER, Peterson SK et al. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 1999: 8 (4 Pt 2): 353-360.
34. Gritz ER, Peterson SK, Vernon SW et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005: 23 (9): 1902-1910.
35. Burton AM, Peterson SK, Marani SK et al. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control 2010: 21 (4): 513-521.
36. DiMatteo MR, Hays RD, Gritz ER et al. Patient adherence to cancer control regimens: scale and development and initial validation. Psychol Assess 1993: 5 (1): 102-112.
37. Kenward MG, Rogers JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997: 53: 983-997.
38. Kiviniemi MT, Bennett A, Zaiter M, Marshall JR. Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior. Psycho-Oncology 2011: 20: 1023-1033.
39. Huang M, Sun C, Boyd-Rogers S et al. Prospective study of combined colon and endometrial cancer screening in women with Lynch syndrome: a patient-centered approach. J Oncol Pract 2011: 7 (1): 43-47.